The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2011-12-01
|
| Sarja: | Oncology Reviews |
| Aiheet: | |
| Linkit: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|